Indication for lung transplantation in advanced cystic fibrosis;Indikation zur lungentransplantation bei fortgeschrittener zystischer fibrose

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 39, 2000, Pages 1352-1360

  Speich, R ^a   Boehler, A ^a   Spiliopoulos, A ^a   Weder, W ^a   Nicod, L P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cystic fibrosis surgery; Lung transplantation

Indexed keywords

CYSTIC FIBROSIS; DISEASE COURSE; HUMAN; LIVER DISEASE; LUNG FUNCTION; LUNG TRANSPLANTATION; NUTRITIONAL STATUS; OSTEOPOROSIS; PHYSICAL PERFORMANCE; PLEURODESIS; RECURRENT INFECTION; REVIEW; TREATMENT INDICATION; WEIGHT REDUCTION;

BACTERIAL INFECTIONS; CYSTIC FIBROSIS; ENGLISH ABSTRACT; HUMAN; LUNG TRANSPLANTATION; RESPIRATORY FUNCTION TESTS;

EID: 0034734717     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Cystic fibrosis
2. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital
3. Improved results of lung transplantation for patients with cystic fibrosis
4. Heart-lung transplantation. Successful therapy for patients with pulmonary vascular disease
5. Die isolierte lungentransplantation - Evaluation von patienten und erste resultate
6. Die isolierte lungentransplantation
7. Heart-lung transplantation in cystic fibrosis - Overview
8. Unilateral lung transplantation for pulmonary fibrosis
9. Bilateral sequential lung transplantation: The procedure of choice for double-lung replacement
10. Bilateral lung transplantation for cystic fibrosis
11. Lung transplantation
12. Single lung transplantation with simultaneous contralateral pneumonectomy for cystic fibrosis
13. Single lung transplantation for cystic fibrosis: Is it an option?
14. Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children
15. Heart-lung-liver transplantation
16. End-stage cystic fibrosis: Improved diabetes control 2 years after successful isolated pancreatic cell and double-lung transplantation
17. Living-donor lobar lung transplantation experience: Intermediate results
18. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report - 1999
19. Cystic fibrosis. Target population for lung transplantation in North America in the 1990s
20. Lung transplantation for cystic fibrosis: Special considerations
21. Lung transplantation in cystic fibrosis: Consensus conference statement
22. Lung transplantation for cystic fibrosis
23. Prediction of mortality in patients with cystic fibrosis
24. Risk of death in cystic fibrosis patients with severely compromised lung function
25. Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation
26. Analysis of cystic fibrosis referrals for lung transplantation
27. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis
28. Severe osteoporosis before and after lung transplantation
29. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease
30. Correlates of osteopenia in patients with cystic fibrosis
31. Osteopenia in adults with cystic fibrosis
32. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
33. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin
34. Intermediate-term results of heart-lung transplantation for cystic fibrosis
35. Lung transplantation after previous thoracic surgical procedures
36. Heart-lung transplantation for patients with cystic fibrosis. A test of clinical wisdom
37. Lung transplantation for mechanically ventilated patients
38. Double-lung transplantation in mechanically ventilated patients with cystic fibrosis
39. Non-invasive mechanical ventilation for cystic fibrosis patients - A potential bridge to transplantation
40. Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure
41. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage
42. Infectious complications of lung transplantation. Impact of cystic fibrosis
43. Saprophytic fungal infections and lung transplantation - Revisited
44. Infection after lung transplantation
45. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
46. Allergic bronchopulmonary aspergillosis in lung allograft recipients
47. Recurrence of allergic bronchopulmonary aspergillosis in the posttransplant lungs of a cystic fibrosis patient
48. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation
49. Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis
50. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis
51. The potential of nosocomial transmission of Pseudomonas cepacia exists at cardiopulmonary transplant centers
52. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis
53. PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection
54. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis
55. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia
56. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain
57. Nontuberculous mycobacterial pulmonary disease in cystic fibrosis
58. Selection and evaluation of recipients for heart-lung and lung transplantation